Journal Logo

Articles by S. Abi Nehme

ENASIDENIB ASSOCIATED WITH IMPROVED SURVIVAL COMPARED WITH STANDARD OF CARE FOR R/R AML PATIENTS WITH AN IDH2 MUTATION BASED ON DATA FROM STUDY AG221-C-001 AND A REVIEW OF PATIENT CHARTS IN FRANCE: PS1026

de Botton, S.; Brandwein, J.; Wei, A.; More

HemaSphere. 3:462-463, June 2019.

TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH IDH2-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA - A FRENCH MEDICAL CHART REVIEW ANALYSIS: PS1041

Pigneux, A.; Quesnel, B.; Thomas, X.; More

HemaSphere. 3:470-471, June 2019.